Interestingly, higher basal plasma activity of VAP-1/SSAO in the acute phase of ischemic stroke predicts the increased incidence of intracranial hemorrhage after intravenous infusion of tissue plasminogen activator (tPA) to restore brain perfusion (Hernandez-Guillamon et al., 2010). The gene discussed is AOC3; the disease is ischemic stroke.